Evidence that Argos is an antagonistic ligand of the EGF receptor

Oncogene

Volumn 19, Issue 31, 2000, Pages 3560-3562

  Vinós, Javier ^a,b   Freeman, Matthew ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^b INSTITUTO DE NEUROCIENCIAS   (Spain)

Author keywords

Antagonist; Argos; Drosophila; EGF receptor; Growth factor; Receptor tyrosine kinase

Indexed keywords

ARGOS; EPIDERMAL GROWTH FACTOR RECEPTOR; LIGAND; SECRETORY PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL SPECIFICITY; CHIMERA; DROSOPHILA; HUMAN; HUMAN TISSUE; LIGAND BINDING; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ARACHNIDA; HEXAPODA; MAMMALIA;

EID: 0034691829     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203702     Document Type: Article

References (11)

1. Casci T and Freeman M. (1999). Cancer Metastasis Rev., 18, 181-201.
2. Freeman M. (1996). Cell, 87, 651-660.
3. Freeman M, Klämbt C, Goodman CS and Rubin GM. (1992). Cell, 69, 963-975.
4. Gabay L, Seger R and Shilo B-Z. (1997). Science, 211, 1103-1106.
5. Golembo M, Schweitzer R, Freeman M and Shilo B-Z. (1996). Development, 122, 223-230.
6. Howes R, Wasserman JD and Freeman M. (1998). J. Biol. Chem.. 273, 4275-4281.
7. Lohmeyer M, Mason S and Gullick WJ. (1997). Int. J. Oncol., 10, 677-682.
8. Reichman-Fried M, Dickson B, Hafen E and Shilo B-Z. (1994). Genes Dev., 8, 428-439.
9. Schweitzer R, Howes R, Smith R, Shilo B-Z and Freeman M. (1995). Nature, 376, 699-702.
10. Stemerdink C and Jacobs JR. (1997). Development, 124, 3787-3796.
11. van de Poll MLM, van Vugt MJH, Lenferink AEG and van Zoelen EJJ. (1997). Biochem., 36, 7425-7431.